What is the diagnosis and management for a patient with a diastolic filling E/A ratio of 0.69, MV E' tissue velocity of 9.8 cm/sec lateral and 6.4 cm/sec medial, and E wave deceleration time of 236ms, suggesting possible diastolic dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Grade I Diastolic Dysfunction with Normal Filling Pressures

This patient has Grade I diastolic dysfunction characterized by impaired left ventricular relaxation with normal filling pressures, requiring treatment of underlying etiologies (hypertension, coronary disease) rather than aggressive diuresis. 1, 2

Diagnostic Interpretation

Your echocardiographic parameters definitively establish Grade I diastolic dysfunction:

  • E/A ratio of 0.69 falls well below the diagnostic threshold of ≤0.8 that defines impaired relaxation 1, 2
  • E' velocities (lateral 9.8 cm/sec, medial 6.4 cm/sec) indicate delayed myocardial relaxation, with the medial value below the normal cutoff of <7-8 cm/sec 1, 3
  • E wave deceleration time of 236 ms is prolonged (normal is typically <200 ms), consistent with impaired relaxation rather than restrictive physiology 1
  • Estimated E/e' ratio would be approximately 8-10 (assuming E velocity around 50-70 cm/sec), confirming normal filling pressures since values <8 indicate normal LAP 1

The pattern shows classic impaired relaxation without elevated left atrial pressure—the hallmark of early diastolic dysfunction. 1, 2

Critical Distinction: Not Pseudonormalization

You must exclude pseudonormalization (Grade II dysfunction masquerading as normal), which would indicate elevated filling pressures despite seemingly normal parameters. 1, 4

Key differentiating features confirming true Grade I (not pseudonormal):

  • E/A ratio <0.8 with E velocity likely ≤50 cm/sec rules out pseudonormalization 1
  • If E/A were 0.8-2.0, you would need additional parameters: LA volume index, TR velocity, and potentially Valsalva maneuver 1
  • Valsalva maneuver can unmask pseudonormalization: if E/A decreases by >0.5, this reveals elevated filling pressures 1

Common pitfall: An E/A ratio appearing "normal" (0.8-2.0) in post-MI or heart failure patients often represents pseudonormalization with high filling pressures, not true normal function. 4 Your ratio of 0.69 avoids this diagnostic trap.

Additional Parameters to Confirm Grade I

Complete the assessment with these measurements to definitively confirm normal filling pressures: 1, 3

  • LA volume index should be <34 mL/m² (elevated values indicate chronic pressure elevation and at least Grade II dysfunction) 1, 3
  • TR velocity should be <2.8 m/sec (higher values suggest elevated pulmonary pressures) 1, 3
  • Pulmonary vein flow should show S/D ratio >1 (reversal suggests elevated pressures) 1

If only one of these three parameters meets cutoff values for abnormality, LAP remains normal and Grade I is confirmed. If two or more are abnormal, the patient has Grade II dysfunction with elevated LAP. 1

Management Algorithm

Primary Treatment: Address Underlying Etiologies

Do not treat the echocardiographic findings—treat the disease causing them. 5, 6

  1. Hypertension control (most common cause):

    • First-line: ACE inhibitors or ARBs to control blood pressure, promote LV hypertrophy regression, and directly improve ventricular relaxation 5, 7
    • Target BP <130/80 mmHg in most patients 7
  2. Heart rate control:

    • Beta-blockers to lower heart rate and increase diastolic filling time, particularly beneficial with concomitant coronary disease 5, 6
    • Longer diastole allows more complete relaxation 6
  3. Coronary disease management:

    • Relieve myocardial ischemia aggressively, as ischemia profoundly impairs relaxation 6, 8
    • Consider stress testing if not recently performed 5
  4. Metabolic optimization:

    • Control diabetes, treat obesity, manage hyperlipidemia 5, 6

Diuretic Use: Exercise Extreme Caution

Critical warning: Aggressive diuresis is contraindicated in Grade I diastolic dysfunction with normal filling pressures. 9

  • Stroke volume decreases more dramatically with volume depletion in diastolic dysfunction than systolic dysfunction 9
  • Only use diuretics if clinical volume overload is present (peripheral edema, pulmonary congestion) 9
  • With normal LAP (as your parameters suggest), diuretics will worsen cardiac output 9

Monitoring Strategy

Regular surveillance is mandatory to detect progression: 5

  • Repeat echocardiography every 6-12 months initially 5
  • Watch for indirect signs of progression to Grade II:
    • LA dilatation (volume index >34 mL/m²) 1, 3
    • Rising E/e' ratio (>14 indicates elevated pressures) 1, 3
    • Shortening deceleration time (approaching <160 ms) 1, 3
  • Consider diastolic stress testing if symptoms develop despite normal resting parameters 5

Progression to Higher Grades

Grade III (restrictive filling) would show: 1, 3

  • E/A ratio ≥2.0 with DT <160 ms
  • Severely reduced e' velocities (3-4 cm/sec)
  • Markedly elevated E/e' ratio (>14)
  • This pattern indicates severely elevated LAP and poor prognosis 1

Prognosis

Grade I diastolic dysfunction carries relatively favorable prognosis compared to systolic dysfunction: 6

  • Annual mortality approximately 8% (versus 19% with systolic dysfunction) 6
  • However, morbidity can be substantial, particularly in elderly patients 6
  • Early recognition and treatment of underlying causes prevents progression to symptomatic heart failure 6, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diastolic Dysfunction Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diastolic Dysfunction Diagnosis and Progression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Grade I Diastolic Dysfunction with Normal E/E' Ratio

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diastolic heart failure.

Cardiovascular research, 2000

Research

Treatment of diastolic dysfunction in hypertension.

Nutrition, metabolism, and cardiovascular diseases : NMCD, 2012

Research

Diastolic dysfunction.

The Canadian journal of cardiology, 1996

Research

Diastolic dysfunction and heart failure: causes and treatment options.

Cleveland Clinic journal of medicine, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.